The use of pleuroperitoneal shunts in the management of persistent chylothorax in infants

https://doi.org/10.1016/S0022-3468(99)90192-6Get rights and content

Abstract

Background/Purpose: The development of chylothorax is a serious and often life-threatening clinical entity that may cause profound respiratory, nutritional, and immunologic complications and has become increasingly common in recent years. Optimal management of this problem has not been well defined because medical therapy has a significant failure rate. Surgical treatment of complicated chylothorax has become a mainstay of care.

Methods: Over the last 36 months, seven infants had a pleuroperitoneal shunt placed for the management of refractory chylothorax. Ages ranged from 10 to 66 days with a weight between 1,000 to 4,850 g. Five of the seven infants were ventilator dependent. The etiologies were congenital in four and acquired in three with one related to a cardiothoracic procedure, one related to superior vena caval thrombosis, and one postoperative diaphragmatic hernia repair with superior vena caval thrombosis. Associated conditions included a left congenital diaphragmatic hernia, asplenia, isolated renal agenesis, bronchopulmonary dysplasia, and a patent ductus arteriosus. Each patient was unresponsive to thoracentesis, tube thoracostomy, and dietary manipulation with preoperative volume of chest tube output ranging from 50 to 162 cc/kg/d. The duration of preoperative therapy in congenital occurrences ranged from 10 to 46 days (average, 22 days). A Denver double-valved shunt system was used and catheters were implanted under general anesthesia. Manual pumping was required postoperatively on an hourly basis.

Results: All seven patients had excellent results with the elimination of the chylothorax and resolution of symptoms. There were two complications. Shunt survival rate was six of seven (86%). Shunt removal ranged from 24 to 79 days (average, 44 days). Patient survival rate was five of seven (71%) with one infant dying of progressive pulmonary disease and one infant dying from viral sepsis; both had functioning shunts. One patient remains ventilator dependent secondary to chronic lung disease from prematurity.

Conclusions: Pleuroperitoneal shunting is safe, simple, and an effective treatment of chylothorax in infants despite their size, age, or degree of prematurity.

References (14)

There are more references available in the full text version of this article.

Cited by (57)

  • Compressive chylothorax after lumbar spine fracture

    2019, Archives de Pediatrie
    Citation Excerpt :

    Thoracic duct embolization is another option to control the leakage [2,17]. Pleuroperitoneal shunts can be used for refractory chylothorax [18]. Post-traumatic chylothorax is a rare condition, especially in children.

  • Nutrition and metabolism in the critically ill child with cardiac disease

    2018, Critical Heart Disease in Infants and Children
  • Diaphragmatic fenestration for refractory chylothorax after congenital cardiac surgery in infants

    2017, Journal of Thoracic and Cardiovascular Surgery
    Citation Excerpt :

    Although chemical pleurodesis is a safe and attractive alternative in neonatal patients because it can be accomplished via a minimally invasive procedure, it has mixed efficacy, with some reports documenting the need for multiple interventions. The well-documented significant pain associated with pleurodesis and the potential for respiratory compromise, lymph edema, and pulmonary fibrosis present a significant risk to patients with comorbid congenital heart disease3,7,22-24 (Table 2). Pleuroperitoneal shunts have been efficacious in infants, with limited data of use in older children.

  • Pleurodesis with povidone–iodine for refractory chylothorax in newborns: Personal experience and literature review

    2015, Journal of Pediatric Surgery
    Citation Excerpt :

    Our criteria are more cautious than other previously reported to avoid general failure in these fragile patients with high chyle daily output. Regarding the best second-line treatment, different surgical approaches (pleuroperitoneal shunting, pleurectomy, surgical pleurodesis, thoracic duct ligation) have been proposed, with no definitive success [16–20]. Surgical duct ligation and video-assisted surgical pleurodesis/pleurectomy are the most commonly used surgical procedures after õfailure of conservative treatment [16].

View all citing articles on Scopus

Presented at 45th Annual International Congress of the British Association of Paediatric Surgeons, Bristol, England, July 21–24, 1998.

View full text